News, Links and Commentary
Wednesday, September 06, 2006
Diary of an MD Patient Treated with Avastin
New Zealander Simon James is about to undergo his second treatment with Avastin for myopic macular degeneration. Simon is 22 years old and significantly younger than most people affected by macular degeneration. You can read about his treatment, which has so far brought positive results, in My Eyes Diary.
Avastin is the drug produced by Genentech and which some ophthalmologists are using as a cheaper alternative to Genentech's Lucentis.
Avastin is the drug produced by Genentech and which some ophthalmologists are using as a cheaper alternative to Genentech's Lucentis.
Comments:
Post a Comment
Links to this post:
